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Abstract Chalcones are absorbed in the daily diet and
appear to be promising cancer chemopreventive agents.
Chalcones represent an important group of the polyphenolic
family, which includes a large number of naturally occurring
molecules. This family possesses an interesting spectrum of
biological activities, including antioxidative, antibacterial,
anti-inflammatory, anticancer, cytotoxic, and immuno-
suppressive potential. Compounds of this family have been
shown to interfere with each step of carcinogenesis,
including initiation, promotion and progression. Moreover,
numerous compounds from the family of dietary chalcones
appear to show activity against cancer cells, suggesting that
these molecules or their derivatives may be considered as
potential anticancer drugs. This review will focus primarily
on prominent members of the chalcone family with an
1,3-diphenyl-2-propenon core structure. Specifically, the
inhibitory effects of these compounds on the different steps
of carcinogenesis that reveal interesting chemopreventive
and chemotherapeutic potential will be discussed.
Keywords Diet  Chalcone derivatives 
Chemoprevention  Chemotherapy
Introduction
Polyphenols represent one of the most prevalent classes of
compounds found in our daily diet [171]. Over the last ten
years, increasing attention has been dedicated to chalcones
because of their interesting biological activities. Indeed,
chalcones constitute an important group of natural com-
pounds that are especially abundant in fruits (e.g., citruses,
apples), vegetables (e.g., tomatoes, shallots, bean sprouts,
potatoes) and various plants and spices (e.g., licorice),—
many of which have been used for centuries in traditional
herbal medicine [29]. Chemically, chalcones are open-
chain flavonoids bearing two aromatic rings linked by a
three-carbon enone moiety (Fig. 1). The majority of the
content of chalcones in citrus fruits and various plants is
mediated through the formation of 4,20,40,60-tetrahydroxy-
chalcone (also known as naringenin chalcone (1)) by
chalcone synthase (Fig. 2) [77]. Naringenin chalcone (1)
also plays an essential role in the flavonoid biosynthetic
pathway and contributes significantly to the total amount of
plant flavonoids [35]. Although chalcones occur naturally,
they could be available in larger amounts through an effi-
cient and simple synthesis. Briefly, synthesis through base-
catalyzed Claisen–Schmidt condensation of an aromatic
aldehyde and an appropriate ketone in a polar solvent
(methanol or ethanol) renders them a readily available
nutrition component/supplement in either natural or syn-
thesized form [147] (Fig. 3).
The present paper is primarily concerned with chalcone
derivatives found in edible plants, fruits, and vegetables
and with their positive effects in cancer chemoprevention
and carcinogenesis. Cancer chemoprevention can target
each step of carcinogenesis with natural or synthetic sub-
stances [160]. Because of unsatisfactory cancer treatment
options and adverse side effects caused by currently used
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chemotherapeutic compounds, great emphasis has been put
on the use of non-toxic dietary substances and botanical
products, either alone or in a co-treatment.
Various chalcones completely inhibit different steps of
carcinogenesis from the very early stages, including tumor
initiation, through promotion, progression, angiogenesis,
and invasion, to the very late stages leading to metastasis.
They are also strongly implicated in the negative regulation
of cell cycle progression and favor cell death mechanisms,
predominantly apoptosis, in transformed cells. Moderation
of these processes is generally associated with the involve-
ment of chalcones in an elaborate network of inflammatory
cell-signaling pathways that largely contribute to tumor
promotion.
This review will focus on members of the chalcone class
with the 1,3-diphenyl-2-propenon core structure and the
inhibitory effect of these compounds on the different steps
of carcinogenesis that highlight their interesting chemo-
preventive and chemotherapeutic potential.
Inflammation cell-signaling pathways targeted
by chalcones
The tight interplay between chronic inflammation and cancer
was first established and carefully documented by Virchow
in 1863 when he observed leukocytes in neoplastic tissues.
Since then, many scientists have provided evidence under-
lining the strong dependency between these two processes.
Natural compounds, including chalcones, have been shown
to interact with, abrogate, and abolish inflammatory signal-
ing (see Fig. 4). Moreover, a single compound can target
multiple signaling events and contribute to inhibition of the
synthesis of inflammatory mediators.
Nuclear factor (NF)-jB is a mediator of inflammatory
diseases and cancer and has been shown to induce resistance to
various chemotherapeutic agents. This transcription factor is
implicated in immunity, anti-apoptosis, proliferation, and
activation of more than 550 target genes involved in tumor
promotion, angiogenesis, and metastasis. The canonical NF-
jB pathway is characterized by a cascade leading to activation
of the functional heterodimer p50/p65. After stimulation by
tumor necrosis factor (TNF)a, activation of the Ij kinase
(IKK) complex leads to phosphorylation of the inhibitory
subunit IjBa followed by subsequent proteasomal degrada-
tion. As a result, NF-jB p50/p65 translocates to the nucleus
and transcription is activated.
Besides NF-jB signaling, other pathways are strongly
linked to inflammation processes, including extracellular
signal-regulated kinase (ERK), c-Jun N-terminal kinases
(JNK), and p38 signal transduction pathways. The ERK1/
2-mediated signaling pathway is activated by growth fac-
tors, cytokines, carcinogens, or viral proteins. Initially, this
pathway was thought to be limited exclusively to cell
growth and proliferation, but there is growing evidence
indicating its involvement in several inflammatory pro-
cesses [136]. The family of JNK enzymes is implicated in
cell proliferation, survival, and apoptosis through the
activation of stress and inflammation. Inhibition of JNK-
mediated AP-1 activation is a promising approach for
inhibition of the inducible expression of inflammatory
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Fig. 1 Schematic representation of main polyphenol family mem-
bers. Polyphenols are subdivided into 4 main classes—phenolic acids,
flavonoids, stilbenes, and lignans—according to the number of phenol
rings they include and the structural elements that bind these rings
together [114]. Flavonoids can be further divided into various
subclasses of which chalcones, flavonols, flavones, flavanones,
anthocyanidins, and isoflavonoids are the most common. The core
1,3-diphenyl-2-propenon chalcone structure is shown
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Fig. 2 Biosynthesis of naringenin chalcone in plants and citruses.
The condensation of three molecules of malonyl-CoA and one
molecule of 4-coumaroyl-CoA is catalyzed by chalcone synthetase
resulting in the formation of naringenin chalcone, which acts as a
substrate for further synthesis of flavonoids
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genes in cancer and other pathologies [115]. The p38 mitogen-
activated protein kinase (MAPK) pathway is critical for the
synthesis and activity of multiple pro-inflammatory cytokines
(TNF-a, interleukin (IL)-1, IL-6, IL-8).
Finally, the crosstalk of these pathways with NF-jB cell
signaling contributes to induction of key inflammatory
enzymes such as cyclooxygenase (COX)-2 and inducible
nitric oxide synthase (iNOS) [27].
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Fig. 3 Chemical structures of naturally occurring chalcone derivatives
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It has been reported that chalcone (10) provided two
distinct cytoprotective mechanisms, depending on the
duration of pre-treatment. Initially, chalcone (10)
abrogated time and dose dependently the activation of
signal transducer and activator of transcription (STAT)3
and NF-jB in IL-6 and lipopolysaccharide (LPS)-
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stimulated endothelial cells via depletion of intracellular
glutathione (GSH) levels. Prolonged chalcone treatment
(after 6 h and 12 h), however, rescued the intracellular
GSH level, indicating the activation of thiol-related genes.
This second cytoprotective mechanism involved the chal-
cone-mediated accumulation of NFE2-related factor (Nrf)2
in the nucleus, which led to elevated protein levels of
thioredoxin reductase and heme oxygenase (HO)-1 [108].
Heme oxygenase-1 plays an important role in inflam-
matory responses. Its activity catalyzes heme degradation,
leading to the production of carbon monoxide (CO) and
biliverdin, which is further reduced to bilirubin. Heme
oxygenase-1 activity results in cytoprotection against
oxidative injury and cellular stresses [5]. As reported, the
prenylated chalcone 7,9,20,40-tetrahydroxy-8-isopentenyl-
5-methoxychalcone (19) from Sophora flavescens suc-
cessfully inhibited expression of interferon (INF)-c and
tumor necrosis factor alpha (TNF-a)-induced chemokines
(TARC/CCL17, MDC/CCL22, CTACK/CCL27) via induction
of HO-1 [22].
Licochalcone A (18) strongly inhibited NF-jB nuclear
localization along with the subsequent DNA binding and
transcriptional activities induced by TNF-a. Mechanistic
studies with licochalcone A (18) uncovered the underlying
mechanism; the repression was not due to impairment of
receptor-interacting protein (RIP) or IKK-b recruitment to
tumor necrosis factor receptor (TNFR)1 but rather arose
from inhibition of IKK activation and subsequent IjB
degradation. The authors suggested that cysteine 179 of the
IKK complex is essential for licochalcone A-induced IKK
inhibition [39]. Interestingly, Furusawa et al. [41] demon-
strated that if NF-jB was induced by LPS, the effect of
licochalcone A (18) appeared further downstream at the
level of p65. Licochalcone A (18) strongly inhibited
phosphorylation of p65 at serine 276 leading to abrogation
of its interaction with p300 and subsequent reduction in
NF-jB transactivation. Later on, a similar mechanism
leading to inhibition of LPS-induced NF-jB activation was
also confirmed for licochalcone B (20) and licochalcone D
(21) together with reduced LPS-induced production of
nitric oxide (NO), TNF-a, and monocyte chemoattractant
protein (MCP)-1 [40].
A similar mechanism was observed for cardamonin (22),
a natural product from Artemisia absinthium. NF-jB acti-
vation and related iNOS production in LPS-stimulated cells
were inhibited by a direct effect on the capacity of the
transcription factor to bind DNA [50]. Interestingly,
Israf et al. [60] reported inhibition of COX-2 and iNOS
expression by cardamonin (22) via dose-dependent sup-
pression of IjBa phosphorylation and degradation in
LPS-induced RAW 264.7 macrophages, clearly describing
a cell-type-specific effect of this compound. A similar
effect on the NF-jB pathway was reported for broussoch-
alcone A (6) by Cheng et al. [19].
Additionally, inhibition of NF-jB activity by downregu-
lation of the IKK complex has been reported for flavokavain A
(23), which is isolated from Piper methysticum. p38-regu-
lated/activated kinase (PRAK) and MAPK-activated protein
kinase (MAPKAP-K)-3 were also suppressed, as demon-
strated by a group from Scotland and Luxembourg [36].
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Modification of IKK and p65 cysteine residues after
xanthohumol (5) treatment of leukemia cells was described
by Harikumar et al. [48] Xanthohumol (5) downregulated
both constitutive and inducible NF-jB activities. Further-
more, direct inhibition of IKK activation was related to
xanthohumol-mediated alteration of the cysteine 179 resi-
due, whereas direct binding inhibition of p65 to DNA could
be linked to modification of a p65 cysteine residue. Cho et al.
[21] demonstrated that in INF-c-stimulated RAW 264.7
macrophages, xanthohumol (5) inhibited binding activity of
STAT-1a and interferon regulatory factor (IRF)-1.
Hydroxy safflor yellow A (24), the main active mono-
mer of Carthamus tinctorius, significantly inhibited phos-
phorylation of IjBa and subsequent p65 transactivation by
preventing its translocation to the nucleus. The transcrip-
tional level of pro-inflammatory cytokines TNF-a, IL-1a,
and IL-6 was reduced, while mRNA expression of anti-
inflammatory cytokine IL-10 was potentiated [18].
Naringenin chalcone (1), abundant in tomato skin,
inhibited in a dose-dependent manner the production of
pro-inflammatory mediators such as TNF-a, MCP-1, and
NO in LPS-stimulated macrophages [53].
Kim et al. [70] reported that the anti-inflammatory
properties of isoliquiritigenin (2) are mediated by down-
regulation of iNOS, COX-2, TNF-a, and IL-6. These pro-
teins were downregulated by inhibition of NF-jB via
suppression of IKK, ERK1/2 and reduction in p38 phos-
phorylation. Inhibition of NF-jB activation by blocking the
phosphorylation and subsequent degradation of IjBa has
also been reported independently by Kumar et al. and
Kwon et al. [81, 84]. Isoliquiritigenin (2) potentiated HO-1
expression through the ERK1/2 pathway in RAW 267.4
cells, thus effectively inhibiting macrophage-derived
inflammation [93]. In prostate cancer cells, isoliquiritigenin
(2) inhibited cancer cell invasion and migration by abro-
gating JNK/AP-1 signaling [83].
Fig. 4 Involvement of naturally occurring chalcone derivatives in the
NF-jB inflammation pathway. 1a TNFa and/or 1b LPS ligands
interact with corresponding receptors, recruiting several signaling
proteins to form a primary signaling complex. 2 Transmission of
signal resulting in IKK activation. 3 IKK subsequently phosphorylates
serines 32 and 36 of the IjB inhibitor, 4 which in turn creates binding
sites for ubiquitination and shifts IjB to proteasomal degradation.
5 NF-jB subunits are released from the inhibitor complex and
translocated to the nucleus where they bind DNA and activate
transcription of several genes. Chalcone derivatives block the NF-jB
pathway at different steps: inhibition of IKK activity (chalcones 5, 18,
23), suppression of IjBa phosphorylation (chalcones 2, 6, 22, 24),
direct inhibition of p65 binding to DNA (chalcones 18, 20, 21) or
reduction in p38 phosphorylation (chalcones 2, 16). Arrows represent
induction/activation and blunt-ended lines represent repression/inac-
tivation. Abbreviations: TNFa tumor necrosis factor alpha, LPS
lipopolysaccharide, IjB inhibitor of kappa B, IKK IjB kinase, NF-jB
nuclear factor kappa B. This figure was generated with ScienceSlides
software
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Butein (16) has been shown to act as an anti-inflam-
matory agent useful in the treatment of intestinal inflam-
mation. In TNF-a-stimulated HT-29 colon adenocarcinoma
cells, butein (16) inhibited p38 phosphorylation and oste-
opontin-mediated IjBa phosphorylation [92]. Moreover,
Pandey et al. [138] investigated the mechanism by which
butein (16) attenuates IjBa phosphorylation. They reported
that IKK is inactivated directly via the cysteine 179 resi-
due. A co-isolated constituent from Butea monospera
extract, isobutrin (25), also displayed potent inhibitory
activity toward IKK complex activity [149].
Similar effects on various inflammatory pathways and
HO-1 activation have been published for a variety of
synthetic chalcone derivatives with structures optimized
for improved functionality [5, 94, 96, 140, 141].
Chalcones as inhibitors of the cell cycles
As mentioned previously, the antiproliferative activity of
chalcone derivatives is tightly linked with cell cycle arrest
and initiation of the cellular apoptotic machinery. Cyclins
and cyclin-dependent kinases (Cdks) are two key regula-
tory factors and are crucial components of cell cycle
progression. Alterations to the expression or post-
transcriptional modifications of these compounds lead to
deregulation of cell cycle functions. Involvement of diverse
chalcone derivatives in these processes has been described
(see Fig. 5).
Chalcone (10) alone showed potential to interact with
cell cycle progression. The simultaneous enhancement of
p21 and p27 expression and reduction of cyclin B1, cyclin
A, and Cdc2 levels leads to G2/M phase arrest in both
human MCF-7 and MDA-MB-231 breast cancer cell lines
as well as in human T24 and HT-1376 bladder cancer cell
lines [57, 158].
Isoliquiritigenin (2) was shown to reduce cyclin D1,
cyclin E, and Cdk4 levels, which together with increased
p27 levels contributed to downregulation of the cyclin
D1–Cdk4 complex and induced early G1 arrest in human
DU145 and rat MLL prostate cancer cells. In addition,
phosphorylation of cell division cycle (Cdc)2 was
enhanced concurrent with reduction of Cdc25c levels,
leading to inactivation of Cdc2–cyclin B1 complexes and
subsequent late G2/M phase arrest [97]. Similarly, pertur-
bation of the cell cycle at the G2/M phase by induction of
universal inhibitors of Cdks, such as p21 (CIP1/WAF1) and
p27, was observed in leukemia CCRF-CEM cells [195],
human cervical cancer HeLa cells [139], uterine leiomy-
oma cells [68], human hepatoma Hep G2 cells [54], human
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Fig. 5 Involvement of naturally occurring chalcone derivatives in
regulation of the cell cycle. Chalcone derivatives may induce ATM
(chalcone 2), which in turn phosphorylates p53, thus decreasing p53/
MDM2 interaction. However, ATM augmentation subsequently leads
to phosphorylation of Chk1 and Chk2 and reduces the level of Cdc25c
resulting in G2/M arrest. By activating inhibitors of Cdks (p21 and
p27), chalcone derivatives may participate in cell cycle arrest in either
G1 or G2/M phase (chalcones 2, 10, 18, 23). Arrows represent
induction/activation and blunt-ended lines represent repression/inac-
tivation. Abbreviations: Cdk cyclin-dependent kinase, ATM ataxia
telangiectasia mutated, Chk checkpoint homolog serine/threonine-
protein kinase, Cdc25c cell division cycle 25 homolog C. This figure
was generated with ScienceSlides software
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lung cancer A549 cells [59], and human prostate cancer
LNCaP cells [65].
Licochalcone A (18) led to G2/M arrest by similar
mechanisms via induction of p21 and p27, attenuation of
Cdks 2, 4, and 6, and downregulation of cyclin D1 in
androgen-independent PC-3 prostate cancer cells [38, 188].
Flavokavain A (23), the major component of the tradi-
tional kava tea consumed predominately by men in Fiji,
Vanautu and Western Samoa, produced cell cycle arrest by
different mechanisms in cells expressing wild-type p53
versus cells expressing mutated p53. In p53 wild-type RT4
cells, flavokavain A (23) mediated arrest in G1 phase by
accumulation of Cdk2 kinase inhibitors p21 and p27. In
p53 mutated cell lines, however, flavokavain A (23) pre-
vented the G2/M transition via persistent activation of
Cdk1 kinase activity and increased levels of cyclin B1,
which counteracted the decreased level of Cdc25C. The
Cdk1-inhibitory kinases Myt1 and Wee1 were suppressed,
allowing Cdk1 to remain dephosphorylated [167].
A promising strategy leading to disruption of aberrant
cell cycle progression of defective cells is attenuation or
abrogation of MDM2/p53 complex formation. The onco-
protein MDM2 inhibits the tumor suppressor protein p53,
which is considered a genome integrity checkpoint. Inac-
tivated p53 has been shown to be expressed in many human
tumors. Stoll et al. [162] reported that chalcone derivatives
might antagonize the interaction between MDM2 and p53
by binding to a subsite of the p53-binding cleft of human
MDM2, thereby releasing p53 from the complex and
restoring its transcriptional activity. The stability of p53
can be further enhanced by activation of ataxia telangiec-
tasia mutated (ATM), which phosphorylates p53 at serine
15, thus decreasing p53/MDM2 interaction. Studies per-
formed by Hsu et al. [58] in human cervical carcinoma
HeLa cells revealed that isoliquiritigenin-mediated cell
cycle blockade in G2/M phase is associated with extended
activation of ATM accompanied by phosphorylation of
Chk2 and Cdc25c and subsequent p53 phosphorylation.
The p53-dependent inhibition of the cell cycle in G1 phase
has been described [55]. Similar patterns have been
reported for butein (16), where the growth of hepatoma
cancer cells was inhibited via ATM augmentation, fol-
lowed by Chk1 and Chk2 phosphorylation and Cdc25c
level reduction leading to G2/M phase arrest [120].
Synthetic chalcones were shown to disrupt the p53-
MDM2 binding, resulting in elevated p53 activity that
explained previously observed anticancer properties [14].
The ability of chalcones to interact with tubulin, leading
to alterations in the microtubule network, indicates another
mechanism that results in cell cycle blockade. In several
cases, the cytotoxicity-mediated inhibition of cell growth
by chalcones correlates with their capability to bind to
tubulin and thereby abrogate microtubule polymerization
[86]. Although there are few known inhibitors of tubulin
assembly among naturally occurring chalcones, a large
library of chalcone analogues was synthesized. Many
showed convincing antimitotic properties as microtubule-
depolymerizing agents with IC50 values of sub-lM and low
lM concentrations (see Table 1) [10, 31, 69, 87].
Chalcones as inducers of cell death mechanisms
The induction of apoptosis is a hallmark of cancer treat-
ment. A large spectrum of chalcone derivatives with pro-
apoptotic properties have been found in various edible or
medicinal plants. Induction of apoptosis in gastric cancer
cells has been reported for 20,40-dihydroxychalcone (29)
isolated from Herba oxytropis [110] and for uvaretin (35),
isouvaretin (36), and diuvaretin (37) from Uvaria acumi-
nata in leukemia cells [125]. Similarly, 20,40-dihydroxy-60-
methoxy-30,50-dimethylchalcone (ON-III) (31) extracted
from buds of traditional Chinese medicinal herb Cleisto-
calyx operculatus, which are used for a preparation of
herbal tea in Vietnam, triggered apoptosis in breast and
leukemia cancer cells [101, 181]. Licochalcone E (38)
isolated from Glycyrrhiza inflata induced apoptosis in
endothelial cells [17].
An important apoptotic cell death mechanism is acti-
vated via the TNF superfamily members, particularly
tumor necrosis factor–related apoptosis-inducing ligand
(TRAIL). TRAIL selectively induces programmed cell
death via interaction with death receptors TRAIL-R1
(DR4) or/and TRAIL-R2 (DR5) in various cancer cells
without a harmful effect on normal tissue. However,
reduced expression of these receptors or elevated expres-
sion of antiapoptotic proteins leads to TRAIL resistance
[169, 189]. The involvement of specific chalcones in
apoptotic cell death is summarized in Fig. 6.
Szliszka et al. [166] showed that chalcone (10) and four
of its natural analogues, licochalcone A (18), isobava-
chalcone (15), xanthohumol (5), and butein (16), strongly
enhanced the apoptosis-inducing potential of TRAIL and
thus sensitized TRAIL-resistant LNCaP prostate cancer
cells.
Cardamomin (22), a chalcone isolated from Catimbium
speciosum, which is used as herbal tea or in essential oils,
enhanced TRAIL-induced apoptosis in TRAIL-resistant
cells. The underlying mechanism includes increased
expression of death receptor (DR)4 and DR5 and reduced
Bcl-xL levels following cardamomin treatment of human
colorectal adenocarcinoma DLD1 cells [134]. Butein (16)
alone has been shown to induce apoptosis in human leu-
kemia HL-60 cells via positive modulation of caspase-3
activity associated with downregulation of Bcl-2 expres-
sion and upregulation of Bax expression [72]. Subtoxic
132 Genes Nutr (2011) 6:125–147
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concentrations of butein (16) in combination with TRAIL
increased expression of DR5 and boosted caspase-3
activity, allowing apoptosis in TRAIL-resistant U937 cells
[71]. Similarly, subtoxic combinations of isoliquiritigenin
(2) and TRAIL rapidly induced apoptosis in colon cancer
HT29 cells by influencing the interaction between TRAIL
and its receptor [186]. In prostate and gastric cancer cells
and human cervical carcinoma HeLa cells, isoliquiritigenin
(2) disrupted the mitochondrial membrane potential,
resulting in mitochondrial apoptotic pathway activation
[58, 64, 111].
A novel approach to the induction of apoptosis is the use
of ‘mitocans’, therapeutic and preventive drugs that pref-
erentially target mitochondria and possess anticancer
activity [146]. Xanthohumol (5) corresponds well to this
definition; it is able to inhibit complexes I-III of the
respiratory chain, which subsequently leads to excessive
superoxide anion radical (O2
-) production in the mito-
chondria. This compound also produces a breakdown of the
mitochondrial membrane potential followed by cyto-
chrome c release as an initial, irreversible step of apoptosis
induction. Thus, mitochondria serve as novel cellular tar-
gets for naturally occurring anticancer drugs [163]. In
addition, apoptosis induction through ROS generation by
xanthoangelol (33), a major constituent of Angelica keiskei,
was described by Motani et al. in neuroblastoma [121].
Another component of this plant, isobavachalcone (15),
induced apoptosis in neuroblastoma by downregulation of
Table 1 Semi-synthetic and synthetic chalcone derivatives as antiproliferative agents
Chalcone derivative Parent natural product (if available) Targeted cellular processes References
15 dihydroartemisinin derivatives Artemisinin (Artemisia annua) Cell viability
Cell proliferation apoptosis
[179]
21 derivatives polyoxygenated on the A ring Tangeretin (Citrus) Cell proliferation [145]
Boronic acid CA-4 analogues:cis-6, trans-6 Combretastatin A4 (Combretum
caffrum)
Cell proliferation
Inhibition of tubulin assembly
[79]
4 analogues Combretastatin A4 (Combretum
caffrum)
Cell proliferation
Inhibition of tubulin assembly
angiogenesis
[78]
97 combretastatin-like chalcones Combretastatin A4 (Combretum
caffrum)
Cell viability
Cell cycle
Inhibition of tubulin assembly
[31]
65 derivatives with basis functionalities Cell proliferation [107]
19 methoxylated derivatives Cell proliferation
Cell viability inflammation
[8]
12 b-chlorovinyl derivatives Cell proliferation inflammation [7]
17 piperidinylchalcones derivatives Cell proliferation
Cell cycle
[106]
RVC-588
(4,40-dihydroxychalcone)
Cell viability
Cell proliferation
Cell death
[156]
20,40,60-tris(methoxymethoxy) chalcone Cell proliferation [95]
40-(p-toluenesulfonylamido)-4-
hydroxychalcone
Cell proliferation [91]
JAI-51 Cell proliferation
Cell cycle
Inhibition of tubulin assembly
[10]
MDL-27048 Cell proliferation
Cell cycle
Inhibition of tubulin assembly
[69]
644 chalcone derivatives Cell proliferation
Cell cycle
Inhibition of tubulin assembly
[87]
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pro-caspase 3 and 9 followed by upregulation of cleaved
caspase 3 and 9 and Bax induction, similar to the effects of
chalcone (10) in human bladder cancer cells [128, 158].
Moreover, no cytotoxicity was observed against non-
transformed cells [128]. A similar mechanism was descri-
bed for isolespeol (39), isolated from the traditional starch
crop Artocarpus communis cultivated in tropical and sub-
tropical regions [33], in human liposarcoma SW-872 cells
[187, 188].
Zi et al. showed evidence that flavokavain A (23), tra-
ditionally consumed by South Pacific Islanders in kava tea
extract, induced apoptosis in bladder cancer cells partially
through both the Bax-dependent, mitochondrial pathway,
and the downregulation of anti-apoptotic proteins like Bcl-
xL, x-linked inhibitor of apoptosis protein (XIAP), and
survivin. Flavokavain A (23) activated caspase 9, caspase
3, and poly (ADP-ribose) polymerase (PARP) cleavage.
Furthermore, loss of mitochondrial membrane potential
was followed by a release of cytochrome c that was linked
to an increased Bax/Bcl-xL ratio [194]. The related chal-
cone flavokavain B (40), which is used in food and
traditional Chinese medicine, exhibits potently caspase-
and mitochondria-dependent apoptotic activity accompa-
nied by cytochrome c release and translocation of Bak to
the mitochondria. Induction of GADD153, which regulates
the expression of several Bcl-2 family members and
enhances ROS production by depletion of glutathione, has
also been observed. In connection with this effect,
flavokavain B (40) reduced the expression of prosurvival
Bcl-2, amplified the expression of proapoptotic Bim, and
triggered intracellular ROS generation in human colon
cancer cells [82]. Similarly, Tang et al. [168] showed that
flavokavain B (40) caused upregulation of Bim and Puma
pro-apoptotic proteins and downregulation of XIAP and
survivin anti-apoptotic proteins in androgen-negative
prostate cancer cells.
Apoptosis is the most frequently observed mechanism of
chalcone-mediated cell death, but it is definitely not the
only mechanism. In addition to apoptosis, licochalcone A
(18) also induced autophagy-related cell death in LNCaP
prostate cancer cells. Suppression of Bcl-2 expression and
downregulation of the mammalian target of rapamycin
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Fig. 6 Involvement of naturally occurring chalcone derivatives in
apoptotic cell death. Chalcones potentiate the extrinsic apoptotic
pathway: chalcones enhance the apoptosis-inducing potential of
TRAIL partially by increased expression of death receptors DR4 and
DR5 (chalcones 2, 5, 10, 15, 16, 18, 22). Chalcones are implicated in
the intrinsic apoptotic pathway: chalcones target mitochondria either
by disruption of the mitochondrial membrane potential (chalcones 2,
5) or by downregulation of anti-apoptotic proteins like Bcl-xL, Bcl-2,
and upregulation of Bax and Bak (chalcones 16, 23, 40). Chalcones
induce apoptosis via positive modulation of caspase-3 activity
(chalcones 10, 15, 16, 23, 39). Arrows represent induction/activation
and blunt-ended lines represent repression/inactivation. Abbrevia-
tions: TNFa tumor necrosis factor alpha, TRAIL TNF-related apop-
tosis-inducing ligand, FasL Fas ligand, FADD Fas-associated death
domain, DD death domain, DED death effector domain, DISC death-
inducing silencing complex, Casp caspase, Bid Bcl-2 interacting
domain, Cyt cytochrome C. This figure was generated with Science-
Slides software
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(mTOR) pathway led to the formation of autophagic vac-
uoles and acidic vesicular organelles, the classical char-
acteristics of autophagy [184].
Effect of chalcones on tumor initiation
The initiation stage of carcinogenesis is closely related to
phase I and II carcinogen metabolism and to elevated
production of reactive oxygen species (ROS) and reactive
nitrogen species (RNS).
Phase I xenobiotic metabolism represents enzymatic acti-
vation that allows processing of pro-carcinogens into carcin-
ogens. However, these metabolites are frequently further
transformed by phase II detoxifying enzymes that deactivate
harmful radicals and electrophiles. Anti-initiation properties
are therefore linked to the inhibition of phase I enzymes
(cytochrome (CYP) P450, 1A1, 1A2, 1B1) and/or the induc-
tion of phase II enzymes (NAD(P)H, quinone reductase (QR),
gluthatione S-transferase (GST)) [44].
Inhibition of this very early step of carcinogenesis is tightly
associated with the well-described antioxidant properties of
natural compounds. Production of scavenging ROS (super-
oxide-, hydroxyl radical, hydrogen peroxide, hypochlorous
acid) and NO leads to prevention of oxidative damage to
DNA, which would otherwise result in oxidative stress-
induced genotoxicity. Overproduction of ROS following the
induction of oxidative stress contributes significantly to tumor
initiation, and a long-term elevation of ROS levels also plays a
role in tumor promotion [80]. Similarly, the involvement of
RNS cannot be exclusively assigned to either the initiation or
the promotion steps of carcinogenesis [133].
It has been shown that chalcones possessing predomi-
nantly hydroxyl and prenyl substituents exhibit important
antioxidant properties, specifically the induction of quinone
reductase activity [45]. Isoliquiritigenin (2) with three
hydroxyl groups acts as a monofunctional inducer of phase
II enzymes, including GST and QR by triggering the
antioxidant response element (ARE) in the promoter region
of the QR gene [20, 24]. Cuendet et al. [25] demonstrated
the ability of isoliquiritigenin to induce QR activity in
colon and GST activity in rat liver tissue. Furthermore,
among 9 isolates identified from Glycyrrhiza glabra,
isoliquiritigenin (2) is one of the three most potent anti-
oxidant compounds exhibiting peroxynitrite scavenging
activity. It has been demonstrated that this compound
inhibits nitric oxide (NO) production [20]. Similarly, 1,2-
dihydroparatocarpin A (3), a prenylated chalcone isolated
from extracts of roots or stolons of licorice, mediated
effective antioxidant protection against peroxynitrite and
nitric oxide [20, 185].
Additionally, isoliquiritin apioside (4), a phytochemical
isolated from the ‘Rlicca’ fraction of Glycyrrhiza glabra,
reduced oxidative stress–induced genotoxicity by inhibiting
hydrogen peroxide and 4-nitroquinoline-1-oxide (4-NQO)
in human peripheral blood lymphocytes [67].
The prenylated chalcone xanthohumol (5), isolated from
beer, strongly inhibited CYP1A activity with an IC50 in the
nM range and almost completely inhibited this activity at
low lM concentrations [42, 51]. Furthermore, a low lM
concentration was sufficient to double the specific QR
activity, which contributes to detoxification by reduction in
reactive quinones to less-reactive hydroquinones [42].
Interestingly, xanthohumol (5) also possessed potent
hydroxyl- and peroxyl radical scavenging activities that
were 8.9- and 2.9-fold higher, respectively, than the ref-
erence compound Trolox. In addition, lipopolysaccharide
(LPS)-induced inducible nitric oxide synthase (iNOS)
expression and the resulting increase in NO production in
RAW 264.7 murine macrophages were decreased in a
dose-dependent manner by xanthohumol (5) [44].
Another prenylated antioxidative chalcone, broussochal-
cone A (6) isolated from Broussonetia papyrifera vent,
inhibited NO production in LPS-stimulated RAW 264.7 cells
in a dose-dependent manner that was independent from a
direct effect on iNOS enzyme activity. From a mechanistic
point of view, this compound seems to suppress the NF-jB
pathway resulting in a decreased level of iNOS expression.
Broussochalcone A (6) also exhibited free-radical scavenging
activity, including superoxide- and hydroxyl-radical inhibi-
tion, which may contribute to its antilipid peroxidation
activity in rat brain homogenates [19].
Several studies indicate that dihydrochalcones exhibit
particularly potent antioxidant properties [23, 118, 151].
Phloretin (7) and its glucoside phloridzin (8), two nat-
urally occurring dihydrochalcones isolated from apples,
displayed strong scavenging potential against peroxynitrite
[151]. Moreover, phloridzin (8) possesses a remarkable
antioxidant activity against superoxide radical, hydrogen
peroxide, and hypochlorous acid [23].
Mathiesen et al. [118] reported that myrigalone B (9)
from the plant Myrica gale is an interesting scavenger of
1,1-diphenyl-2-picrylhydrazyl (DPPH) radical and an inhib-
itor of lipid peroxidation in isolated hepatocytes treated with
tert-butyl hyperoxide.
Interestingly, neohesperidin dihydrochalcone, a hemisyn-
thetic compound used as an intense sweetener and permitted
for a commercial use as a food additive in Europe, is produced
by the hydrogenation of neohesperidin, which is abundant in
citrus fruits. Like phloridzin (8), neohesperidin dihydrochal-
cone exhibits scavenging activities for various ROS with a
preference for non-radical ROS including hydrogen peroxide
and hypochlorous acid [23].
Finally, Makita et al. [113] demonstrated that the dietary
flavonoids chalcone (10) and 2-hydroxychalcone (11) have
an inhibitory effect on 4-NQO-induced oral carcinogenesis.
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Effects of chalcones on tumor promotion
The second phase of carcinogenesis, tumor promotion, is
tightly linked to the initiation phase. Generation and acti-
vation of endogenous tumor promoters (prostaglandins
(PGs), 17b-estradiol (E2)) leads to altered gene expression,
affects chromatin structure and disturbs signal transduction
pathways. Therefore, inhibition of COX-1 and COX-2,
which catalyze the formation of PGs, plays an important
role in the prevention of tumor promotion [165].
Hormones such as 17b-estradiol represent another class
of endogenous tumor promoters that stimulate cell growth
via interaction with estrogen receptors. This interaction
leads to increased risk for breast and uterine cancer [150].
Thus, reduction of endogenous estrogen levels is a prom-
ising strategy to decrease and prevent tumor promo-
tion [43].
Chronic inflammation also generates elevated levels of
NO and contributes to tumor promotion. Xanthohumol (5)
has been shown to successfully inhibit iNOS production
and both COX-1 and COX -2 activities [42, 43]. The
activity of chalcones against inflammatory processes was
demonstrated by Zhao et al. [192], who showed potent
inhibition of LPS-induced NO production without any
cytotoxicity, paralleled by iNOS expression, by xan-
thohumol (5), xanthohumol B (12), xanthohumol D (13),
dihydroxanthohumol (14), and a novel chalcone oxidation
product of xanthohumol (5), all isolated from Humulus
lupulus. Surprisingly, the suppression of NO production
mediated by dihydroxanthohumol, which lacks a double
bond between the a and b positions, showed much weaker
patterns of inhibition than the other 4 chalcones. Alto-
gether, suppression of LPS-induced iNOS protein expres-
sion apparently mediates the inhibition of COX-1 and
COX-2 by xanthohumol (5) [43]. Furthermore, the anti-
estrogen potential of xanthohumol (5) was confirmed by
efficient inhibition of both human recombinant aromatase
and estrogen-mediated induction of alkaline phosphatase
(ALP) in Ishikawa human endometrial adenocarcinoma
cells. Xanthohumol (5) alone does not possess any intrinsic
pro-estrogenic potential [43, 44].
Various chalcone derivatives may positively affect the
suppression of tumor promotion initiated by 7,12-dimeth-
ylbenz[alpha]anthracene (DMBA) and mediated by 12-O-
tetradecanoylphorbol-13-acetate (TPA). Isobavachalcone
(15), isolated from Angelica keiskei, significantly inhibited
in vivo TPA-induced skin tumor promotion in mice [1].
Similar results were obtained with isoliquiritigenin (2), a
phenolic constituent of licorice [20]. This compound
inhibited TPA-independent tumor promotion in mice trea-
ted with DMBA and suppressed TPA-stimulated produc-
tion of PGE2 in intact epidermal cells. However, it seems
that isoliquiritigenin (2) exerts its antitumor-promoting
effect through the lipoxygenase (LOX) inhibition in non-
epidermal cells because it failed to inhibit 12-LOX and
COX in an epidermal subcellular fraction [177]. Ye et al.
[182] recently demonstrated that isoliquiritigenin (2)
inhibits the CYP19 enzyme (aromatase), which catalyzes
rate-limiting step of the conversion of androgens, such as
testosterone and androstenedione to estrogens.
Similarly, the plant tetrahydroxychalcone butein (16) is
a potent aromatase inhibitor that facilitates downregulation
of estrogen synthesis, thereby producing protective effects
against the initiation and promotion of breast cancer [173].
Interestingly, a combination of naringenin chalcone (1),
the main active component of tomato skin, and 4-hy-
droxychalcone (17) effectively inhibited aromatase and
17b-hydroxysteroid dehydrogenase in a low lM range
[88].
Licochalcone A (18), another phytochemical isolated
from licorice, belongs to a family of promising compounds
with potent antitumor activity. In vitro experiments con-
firmed that licochalcone A suppressed the generation of
NO and PGE2 and inhibited the expression of iNOS and
COX-2 induced by LPS in RAW 264.7 cells [85].
Within the polyphenol family, prenylated flavonoids are
leading molecules for the prevention of tumor promotion
due to their unique structure and promising aromatase
inhibitory properties. Semisynthetic chalcone analogues of
the naturally occurring prenylated flavonoid abyssinone II
from Broussonetia papyrifera were tested for their poten-
tial to inhibit CYP19. Surprisingly, only one compound
showed inhibition potential and it was less potent than
racemic abyssinone II. The successful derivative featured
two hydroxyl groups on the A ring and one methoxy group
accompanied by a 3-methylbutyl-2-enyl substituent on B
ring [112].
Effect of chalcones on tumor progression
Uncontrolled cell proliferation, alterations in terminal cell
differentiation, and impairment of apoptosis are key char-
acteristics of tumor cell progression. In this section, we will
focus only on the antiproliferative and toxicity-induced
effects of natural compounds as the involvement of chal-
cone derivatives on cell cycle and cell death mechanisms
we discussed separately.
Severe side effects, such as nephrotoxicity, hepatotox-
icity, ototoxicity, or neurotoxicity, are triggered by cur-
rently used chemotherapeutic agents. These adverse
impacts on health shift the attention to search for novel
drugs among natural compounds with promising bioactiv-
ity that lacks such side effects. Thus, combination of nat-
urally occurring compounds with commercially used
chemotherapy agents is a promising strategy leading to
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reduction in treatment dosage, reduction in side effects,
enhancement of drug efficacy, and reduced drug resistance.
Furthermore, identification of compounds with selective
cytotoxicity to transformed cells would improve tumor
treatment.
Licochalcone A (18) was studied as a candidate for
overcoming cisplatin-induced toxicity. Licochalcone A
(18) reduced the size of solid tumors and induced neither
nephrotoxicity/hepatotoxicity nor oxidative stress. The
suppression of proliferation was moderated through
reduction in DNA synthesis in CT-26 murine colon carci-
noma cells. Oral administration of licochalcone A prior to
cisplatin treatment inhibited cisplatin-induced kidney and
liver damage as indicated by alterations in the serum NO
and tissue lipid peroxidation levels. Licochalcone A (18)
was also able to replenish GSH levels [90].
A similar study of isoliquiritigenin (2) confirmed its role
in reducing chemotherapy-induced kidney and liver toxic-
ity [89]. It was recently reported that isoliquiritigenin (2)
selectively inhibited the proliferation of C4-2 and LNCaP
prostate cancer cells, while a similar dosage range did not
affect the viability of normal IEC-6 epithelial cells [191].
Isoliquiritigenin (2) has also been shown to significantly
reduce viability and proliferation in a dose-dependent
manner in uterine leiomyoma cells, human lung cancer
cells, and CCRF-CEM leukemia cells. These effects were
related to induction of apoptosis and increased cell cycle
arrest [59, 68, 195]. Interestingly, isoliquiritigenin (2)
downregulates proliferation in HL-60 cells and mediates
their monocytic differentiation [100].
Li et al. [102] carried out a detailed phytochemical
investigation into Brazilian red Propolis, considered a
healthy food in various parts of the world, which led to the
isolation of four hydroxychalcone derivatives among more
than 40 compounds. Three out of four chalcones possessed
a conjugated double bound and showed accentuated cyto-
toxicity to murine colon 26-L5 carcinoma, murine B16-
BL6 melanoma, murine Lewis lung carcinoma (LLC),
human lung adenocarcinoma A549, human cervix adeno-
carcinoma HeLa, and human HT-1080 fibrosarcoma cell
lines. However, reduction to the single-bond characteristic
of hydrochalcones impaired the cytotoxic activity. The
authors also stressed the importance of a methoxy sub-
stituent at the C-20 position of the A ring and the absence of
substituents on the B ring as a structure that preferentially
potentiates cytotoxic properties.
Similar observations were published by De Vincenzo
et al. [26] who determined the effects of 15 natural and
synthetic chalcones on ovarian cancer cell proliferation.
The presence of an a-b double bond potentiated the anti-
proliferative properties of the chalcone scaffold.
Butein (16) and a number of other hydroxy- and di-
hydroxychalcones were tested for their cytotoxic effect on
human colon adenocarcinoma cell proliferation. Butein
(16) proved to be the most active compound for growth
inhibition [183].
A batch of prenylated flavonoids, including the chal-
cones xanthohumol (5) and desmethylxanthohumol (26)
isolated from Humulus lupulus, has shown in vitro effec-
tive inhibition of the proliferation of prostate cancer cells.
Xanthohumol (5) appeared to be the most potent com-
pound, whereas the antiproliferative activity of des-
methylxanthohumol (26) was weaker [28]. Furthermore,
xanthohumol (5) inhibited the activity of human DNA
polymerase a, the only initiator of de novo DNA synthesis
among the eukaryotic polymerases [44].
Likewise, dihydrochalcone asebogenin (27), which is
found in several plants, including Piper aduncum, and used
as a condiment and for cocoa flavoring, downregulated the
proliferation of murine B cells [180].
The primary antiproliferative mechanisms related to
growth inhibition in different cancer cell lines are apoptosis
induction and blocking of cell cycle progression. These
mechanisms have been reported for naturally occurring
flavonoids including chalcone (10) (1,3-diphenyl-2-prope-
non) [57, 158], isoliquiritigenin (2) [55, 56], and isoli-
quiritigenin 20-methyl ether (28) isolated from Caesalpinia
sappan [98], butein (16) [120, 137], and 20,40-dihydroxy-
chalcone (29) from Herba oxytropis [110, 187].
In addition, a huge array of hemisynthetic or synthetic
chalcone analogues has been created to identify the most
efficient structure for the inhibition of proliferation (see
Table 1) [9, 91, 95, 145, 148, 156, 179].
Inhibition of invasion
Invasion leads to the localized destruction of normal tissue and
is linked to the highest mortality in patients with cancer either
directly or via metastasis. The first step, local invasiveness,
requires escape of the cancer cells from the epithelium of origin
(primary tumor) and their migration as separate individuals,
known as the epithelial–mesenchymal transition (EMT). The
major role in blocking this process is played by the trans-
membrane glycoprotein E-cadherin. E-cadherin is implicated
in cell–cell adhesion by binding epithelial cells together
through adherent junctions. Furthermore, E-cadherin forms a
complex with catenins, cytoplasmic proteins that link E-cad-
herin to the actin cytoskeleton. E-cadherin/catenin-mediated
intercellular adhesion is essential for the anti-invasive proper-
ties of these proteins. Upregulation of the functions of the
E-cadherin–catenin invasion-suppressor complex by natural
compounds may serve as a target for anti-invasive therapy
[143, 172]. Certain plant molecules have been reported to
interfere with targets involved in invasion [11, 12, 142].
Plant polyphenolic compounds seem to be promising
anti-invasive agents. Xanthohumol (5) and other prenylated
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chalcones exhibit particularly interesting activities [13].
The inhibitory effect of xanthohumol (5) has been shown to
be mediated through positive functional regulation of the
E-cadherin–catenin invasion-suppressor complex [172].
Parmar et al. [143] screened 100 alkaloid and polyphe-
nolic compounds for their anti-invasive potential. The
authors used highly invasive human MCF-7/6 mammary
carcinoma cells, which are known for their ability to invade
a normal tissue segment within 1 week. These cells were
placed in contact with fragments of normal embryonic
chick heart. Anti-invasive effects were observed for chal-
cones presenting a prenyl group. This effect was partially
mediated by selective cytotoxicity to MCF-7/6 cells,
whereas normal heart tissue was not affected.
Furthermore, a series of studies with prenylated and
O-allylated chalcones revealed the importance of methoxy
groups at the C-2 and C-5 positions and the presence of a
bromide atom at the C-3 position of the B ring of the
prenylated derivatives. Among the O-allylated chalcones,
replacement of the B-phenyl ring with a furan-2-yl group
was found to exhibit the strongest anti-invasive properties
[122, 144].
Isoliquiritigenin (2) has been shown to inhibit basal and
epidermal growth factor (EGF)-induced cell migration in a
dose-dependent manner. This compound also affects the
invasion and adhesion of prostate cancer cells. Interest-
ingly, isoliquiritigenin decreased both basal and EGF-
induced activator protein (AP)-1 binding activity and
phosphorylation of Jun N-terminal kinase (JNK), c-Jun,
and Akt. A subsequent downregulation of protein and
mRNA levels of several adhesion molecules (ICAM,
VCAM), growth factors (VEGF), and metalloproteinases
(MMP)-9 was observed [83].
Because of the loss of cell–cell adhesion mediated by
E-cadherin repression and an increase in cell mobility,
growing evidence indicates the importance of epithelial–
mesenchymal transition (EMT) in cancer invasion.
Recently, butein (16) has been implicated in the inhibition
of cell invasion by bladder cancer cells. The underlying
mechanisms include downregulation of the ERK1/2 and
NF-jB signaling pathways associated with reversal of
EMT [190]. Furthermore, Pandey et al. [138] described the
inhibitory impact of butein on cytokine-induced cellular
invasion as a result of the repression of NF-jB-regulated
gene products COX-2 and MMP-9.
Inhibition of angiogenesis
Inhibition of angiogenesis became one of the target strat-
egies of cancer therapy because tumor-induced develop-
ment of new capillary blood vessels is essential for tumor
development, invasion, and metastasis. Angiogenesis and
its inhibition are closely linked to endothelial cells, which
produce the required factors for microtumor expansion
including matrix metalloproteinases (MMPs) and serine
proteases. The activity of these proteins allows endothelial
cells to initiate capillary sprouting [61]. However, inflam-
matory cells, which infiltrate the tumor, become an addi-
tional target for angiogenetic therapy and the prevention of
vascularization. The progressive alteration within the
microenvironment including elevated levels of growth
factors, chemokines, and proteolytic enzymes contributes
greatly to the onset of angiogenesis [3].
Angiogenesis is regulated through multiple signaling
pathways (NF-jB, PI3-K/Akt, ERK1/2, hypoxia-inducible
factor (HIF)-1a), and various mechanisms that lead to
modulation of cytokine profiles or alterations in the
extracellular microenvironment by MMPs. Some important
angiogenic factors are phosphorylation of VEGFR-2 in
human umbilical vein endothelial cells (HUVECs) and
production of basic or acidic fibroblast growth factors
(FGF) and vascular endothelial growth factor (VEGF) in
tumors [2].
Many lines of evidence indicate the prominent role of
plant polyphenols, including members of the chalcone
family, in the fight against pathological angiogenesis (see
Table 2) [6, 16, 32, 34, 37, 46, 49, 103–105, 116, 129–132,
154, 157, 159, 164]. Hydroxy safflor yellow A (24), a
pigment from the flower petals of Carthamus tinctorius,
inhibits blood vessel growth of transplanted gastric ade-
nocarcinoma. Xi et al. [176] described downregulation of
VEGF and bFGF mRNA expression as the underlying
mechanism of inhibition of tumor angiogenesis by this
compound.
Isoliquiritin (30), a chalcone isolated from extract of
licorice root, was identified as a main compound respon-
sible for an anti-angiogenic effect dependent upon antitube
formation [76]. Another licorice-derived flavonoid, isoli-
quiritigenin (2), negatively affects the aberrant expression
of matrix metalloproteinases, which are associated with
activated endothelial and tumor cell invasion, through
inhibition of the JNK- or p38 MAPK pathways. Further-
more, isoliquiritigenin (2) treatment has been shown to
inhibit PMA-induced migration and tube formation [66].
Albini et al. [4] reported that xanthohumol (5) interferes
with the molecular mechanisms of cell migration, invasion,
and survival and affects several different pathways that
result in potent suppression of angiogenesis. Moreover,
oral administration of xanthohumol (5) inhibited angio-
genesis in a dose-dependent manner in vivo due to the
strong reduction in vessel formation, the final morpho-
genesis phase of angiogenesis. Interestingly, higher doses
up to 200 lM produced no adverse health effects, sug-
gesting negligible or no toxicity. From a mechanistic point
of view, xanthohumol (5) has been shown to inhibit the
NF-jB and Akt pathways.
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Cleistocalyx operculatus, a plant used in traditional
Chinese medicine, contains 20,40-dihydroxy-60-methoxy-
30,50-dimethylchalcone (ON-III) (31). This compound is
known to reversibly inhibit the phosphorylation of VEGFR
tyrosine kinase. Additionally, 20,40-dihydroxy-60-methoxy-
30,50-dimethylchalcone abrogates VEGFR-mediated signal
transduction via suppression of MAPK and Akt activation
[78, 126, 135, 152, 174, 193]. Because hydroxylated
chalcones are frequent in nature, 20-hydroxy-40-methoxy-
chalcone (32) was investigated [99]. Previously, the inhi-
bition of PGE2 production by this chalcone was reported to
result from downregulation of COX-2. COX-2 promotes
neovascularization through enhanced prostaglandin pro-
duction and elevated release of angiogenic growth factors
[175]. Furthermore, COX-2 has been detected in the
angiogenic vasculature of tumors and suppression of
angiogenesis by COX inhibitors has been observed [52,
117, 170]. 20-hydroxy-40-methoxychalcone (32) was able to
suppress vascular formation and inhibit excessive angio-
genesis in a bFGF-enhancing matrigel plug assay [99].
Several studies have reported that synthetic or semisyn-
thetic chalcone analogues exhibit anti-angiogenic potential
against HUVEC tube formation, development of sprouts
during an aortic ring assay, or inhibition of endothelial cell
growth in vitro. These compounds include boronic acid
chalcone [78], chalcone analogues related to curcumin [174],
various chalcone derivatives with a substituted backbone
[126, 152], and chalcone carboxylic acid [135].
Inhibition of metastasis
Metastasis, or the ability of cancer cells to infiltrate the
normal tissue surrounding a tumor and to travel to another
non-adjacent organ and create new tumors, is linked with
poor prognosis. The antimetastatic properties of natural
compounds are therefore closely related to their anti-an-
giogenetic and anti-invasive features [73, 190].
Two main components of the roots of Angelica keiskei,
xanthoangelol (33) and 4-hydroxyderricin (34), have been
identified as potent antimetastatic chalcone derivatives [74,
75]. These compounds inhibited tumor growth and lung
metastasis in Lewis lung carcinoma (LLC)-bearing mice,
which led to increased survival time of carcinectomized
mice. Xanthoangelol (33) also suppressed liver metastasis
and the growth of metastasized tumor cells from intra-
splenically implanted LLC. The mechanism of these anti-
metastatic activities has been shown to involve both
inhibition of tumor-induced neovascularization and, more
significantly, inhibition of DNA synthesis in LLC cells.
Yamazaki et al. showed that isoliquiritigenin (2) induced a
significant reduction in metastatic nodules in the lung in a
renal mouse cell carcinoma model. Furthermore, this treat-
ment did not cause leukocytopenia, a common feature of a
large panel of chemotherapeutic drugs. These results indicate
a promising use of isoliquiritigenin (2) as a protective agent
against chemotherapy-induced leukocytopenia.
Although the mechanisms of isoliquiritigenin (2) activ-
ity were not completely elucidated, the authors suggested
that suppression of pulmonary metastasis may result from a
combination of isoliquiritigenin-promoted activation of
macrophages, lymphocytes, and direct cytotoxicity [178].
Butein (16), the biologically active component of Rhus
verniciflua, which is used as a food additive in Korea,
showed in vitro disruption of the clonogenic growth of
small numbers of primary breast cancer cells seeded into
fibroblast co-cultures. These results suggest that butein (16)
may suppress the growth of breast cancer micro-metastases
[153].
Table 2 Plant polyphenols with anti-angiogenic properties
Polyphenolic compound Molecular target References
Red wine polyphenols VEGF, pro-MMP-2, (MT1)-MMP [130, 132]
Green tea polyphenols VEGF, MMP-2, MMP-9 [116]
Epigallocatechin-3-gallate VEGF [16]
Delphinidin
Cyanidin
VEGF [131]
Methylophiopogonanone B VEGF [49]
Luteolin VEGF [6]
Wogonin VEGF [104, 105]
Genistein VEGF, bFGF, uPA, PDGF-A, TF, MMP-2,
MMP-9
[34, 46, 154,
164]
Apigenin HIF-1, VEGF [32]
Chrysin HIF-1, VEGF [37, 103]
Silibinin MMP-2 [159]
Flavonoids (acacetin, apigenin, chrysin, genistein, kaempferol, morin, naringin,
naringenin, rutin)
VEGF [157]
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As metastasis is a chemokine-guided multistep process
based on the dissemination of cancer cells from the primary
tumor into specific organs, the control and/or inhibition of
specific chemokines provides promising targets. Particular
chemokines may promote metastasis by acting directly on
tumor cell migration and invasion. CXC chemokine
receptor 4 (CXCR4) and its only known ligand, CXC
chemokine ligand 12 (CXCL12), are involved in chemo-
tactic regulation of breast cancer metastasis by expressing
non-random patterns in all target organs [123, 124].
Mu¨ller et al. [123] reported that neutralization of the
interaction between CXCL12 and CXCR4 in vivo signifi-
cantly impairs metastasis of breast cancer cells to regional
lymph nodes and to the lung. These results triggered a search
for small neutralizing molecules that are able to inhibit
CXCL12. Hachet-Haas et al. [47] identified several synthetic
chalcone derivatives that reduced binding of CXCL12 to
CXCR4. In particular, the structure of 3-chloro-20-methoxy-
30-hydroxychalcone fits perfectly within the hydrophobic
pocket of CXCL12, producing a high-affinity interaction that
can disrupt the interaction with CXCR4.
Structure–activity relationship
Several studies have focused on the discovery of a struc-
ture–activity relationship in order to better predict the
bioactivity of newly identified chalcone derivatives.
Chalcones that exhibit anti-inflammatory properties
generally feature an a-b unsaturated bond. This allows the
molecule to act as a Michael acceptor for nucleophilic
species including glutathione (GSH) or cysteine residues
on proteins such as IKK-beta [119]. Generally, these target
modifications lead to a major decrease or loss of anti-
inflammatory activities [62].
Several studies have shown that antiproliferative effects
on cancer cells are associated with the presence of one or
more hydroxyl substituents on the chalcone scaffold.
Hydroxyl derivatives of chalcone have more potent anti-
proliferation properties than other chalcone derivatives [15,
26, 109]. Furthermore, the presence of 20-hydroxy group in
a chalcone molecule has been shown to be crucial for the
enhancement of the anti-inflammatory properties of these
molecules. This potent effect was explained by an increase
in the electrophilic properties of an a-b unsaturated ketone
by hydrogen bonding between the 20-hydroxy group and
the ketone moiety (also referred to as the keto, carbonyl, or
enone moiety). Moreover, electron-donating groups on the
A ring could stabilize the GSH adduct by reducing the
acidity of the alpha hydrogen [63, 108].
Modification of chalcone structures by substitution with
a prenyl side chain also affects their biological activities.
Prenylation as protein post-translational modification
results in higher protein lipophilicity and targets the modified
protein to cell membrane. Therefore, it is assumed that pre-
nylation of chalcone molecules might influence their solu-
bility, cellular uptake, and subcellular localization [44].
Compounds with various glycosidic substitutions on the
aromatic rings exhibited attenuated ability to suppress
proliferation relative to the corresponding aglycones. A
possible explanation is that the reduced lipophilicity caused
by the sugar moiety complicates cellular uptake of the
compound by passive diffusion through the cell membrane
[70, 127].
The ability of chalcone derivatives to interact with the
different steps of carcinogenesis has been shown to require
specific structural features.
The structural basis for radical scavenging activity
seems to be the formation of energetically favored intra-
molecular hydrogen bonds. Compounds that can adopt
conformations in which the A ring and the carbonyl group
are orthogonal are more successful radical scavengers
[118].
The inhibitory activity of chalcones on NO production is
believed to be linked to the presence of an a–b double
bond. Molecules with a single bond exhibited a weaker
effect on NO production than corresponding molecules
with an unsaturated bond [192].
Similar mechanisms are valid for the potential of chal-
cones to inhibit the NF-jB pathway. The reduction in the
alkene into a single bond completely attenuates their
inhibition potential [161].
The primary structural feature responsible for microtu-
bule depolymerization activity was hypothesized by com-
parison with the structure of colchicine. Colchicine inhibits
microtubule polymerization by binding to tubulin. The
chalcone possessing 3,4,5-trimethoxyphenyl groups on the
A ring and an a-methyl group within the enone moiety fits
better into the colchicine-binding site of tubulin than other
chalcone derivatives. Thus, alpha-methyl chalcones are
believed to exhibit greater cytotoxic activity than unsub-
stituted analogues [30].
A study of induction of HO-1 by methoxychalcones
revealed that an increasing number of methoxy groups on
the aromatic rings at the 3, 4, 5 and 30, 40, 50 positions
correlated with progressive induction of HO-1, while
methoxy substituents at the 2, 4, 6 positions or alone at the
4 and 40 position were ineffective [155].
Conclusion
Nature offers a large reservoir of bioactive compounds.
The use of these compounds in the treatment of various
diseases, including cancer, might complement or even
substitute for current medical therapeutic strategies.
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Whereas some molecules apparently act via a single
mechanism and thus target one particular cellular process,
many chalcones apparently act as multifunctional com-
pounds. Xanthohumol (5) and isoliquiritigenin (2) are
representatives of this second category. These chalcones
are involved in various steps of carcinogenesis from tumor
initiation to metastasis formation and do not appear to be
specifically targeted. Despite the fact that their mechanisms
seem to be nonspecific, they might nevertheless selectively
target one distinct regulatory protein that modulates many
downstream signaling pathways and thus initiate a cascade
of cellular events that lead to the described spectrum of
effects. Obviously, structural requirements play an essen-
tial role and are correlated to the observed bioactivity.
Therefore, the identification and precise characterization of
naturally occurring chalcones, whether as nutraceuticals or
as novel therapeutic agents, is a promising approach to
fight illnesses such as cancer. Although chalcone deriva-
tives are common in nature, the fast and simple synthesis or
chemical modification of chalcones allows rapid generation
of large numbers of novel compounds that may be useful
for both chemoprevention and inhibition of carcinogenesis.
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